CMS Publishes CPT Codes for Controversial iTind Procedure
- The Centers for Medicare and Medicaid Services has established new CPT codes for the iTind procedure, effective January 1, 2025.
- The new codes include separate ones for insertion and removal of the iTind device for treating BPH.
- This milestone is anticipated to enhance reimbursement options for healthcare providers and improve access for patients.
On November 7, 2024, Olympus Corporation announced that the Centers for Medicare and Medicaid Services (CMS) has published final Category I Current Procedural Terminology (CPT) codes and reimbursement rates for the iTind urological procedure. These new codes, effective January 1, 2025, include one for the insertion (53865) and one for the removal (53866) of the iTind device, aimed at treating benign prostatic hyperplasia (BPH) symptoms. Healthcare professionals regard this as a significant reimbursement milestone for those eligible for the iTind treatment. Healthcare providers can also find additional reimbursement support through Olympus Field Reimbursement Managers. These professionals can offer insights, guidance, and resources pertinent to the iTind reimbursement process. This support aims to facilitate access to the procedure for patients who experience symptoms related to BPH. The clinical research continues to show positive outcomes associated with the iTind procedure. However, there are potential risks, as the iTind device may cause complications such as urinary tract infections. Olympus remains optimistic regarding the enthusiasm of healthcare providers for the procedure based on its benefits reported in ongoing clinical research. The establishment of these CPT codes allows for standardized billing and reimbursement for the treatment, which can improve patient access to this innovative urological solution, thus impacting the landscape for treating lower urinary tract symptoms.